Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
Clinical trial NCT05614115 · COMPLETED
Trial details
- NCT number
- NCT05614115
- Sponsor
- University of Utah
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2025-06-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.